Press Releases From 12/07/2017 Until 12/07/2017

Viewing from to Change
 

Enterprise-DRM/Information Rights Management Market Size Share by Manufacturers, Countries, Type and Application, Forecast to 2022

This report studies the Enterprise-DRM/Information Rights Management market. Information rights management (IRM) is a subset of digital rights management (DRM), technologies that protect sensitive information from unauthorized access. It is sometimes referred to as E-DRM or Enterprise Digital Rights Management. This can cause confusion, because digital rights management (DRM) technologies are typically associated with business to consumer systems designed to protect rich media such as music and video. IRM is a technology which allows for information (mostly in the form of documents) to be remote controlled.

Smart Labels Market Expected to Reach $13,671 Million in 2023

LogoAccording to a new report published by Allied Market Research, titled, Smart Labels Market by Product Type, End-user Industry, and Application. The global smart labels market was valued at $5,428 million in 2017, and is expected to reach $13,671 million by 2023, registering a CAGR of 16.6% from 2017 to 2023. The dynamic display label segment is expected to register the highest CAGR of 17.6% during the forecast period, owing to the enhanced display of the detailed attributes of the product. Asia-Pacific is expected to exhibit the highest growth, owing to the growth in potential startups, rise in disposable income, increase in urbanization & industrialization, along with surge in retail and health & pharmaceutical industries.

Server Microprocessor Market Expected to Reach $16 Billion by 2023

LogoAccording to a new report published by Allied Market Research, titled, Server Microprocessor Market by Design and End User. The global server microprocessor market was valued at $14 billion in 2016, and is projected to reach at $16 billion by 2023, growing at a CAGR of 2.1% from 2017 to 2023. The x86 segment contributed nearly 79% share to the global market in 2016.

Automotive 3D Printing Market, Research and Analysis, 2023

Additive manufacturing or 3D printing allows manufacturers to produce objects using a digital file and wide array of printing materials. Automotive sector, besides aerospace & defense, healthcare, and manufacturing industries, exhibits growth in adoption of the technology. The technology is useful for applications ranging from printing car parts and accessories to manufacturing complex parts in less time as compared to traditional printers. The automotive companies adopt this technology at a remarkable rate in an effort to reduce the manufacturing costs, increase production rate, and lower the material wastage. The 3D printing technology has redefined the process of designing, developing, and manufacturing products in the automotive industry. The technology is being used for producing lighter and complex parts & accessories at reduced costs. Automotive part manufacturers are using 3D printers for effective usage of materials, reducing the lead time, and efficient logistics management. However, lack of skilled labors and high cost of 3D printers restrict the demand for 3D printers to some extent.

Pneumonia Testing Market Estimated to Reach $1,738 Million by 2023

Pneumonia is indicated as a complex infection, which affects the lower part of the respiratory tract along with deposition of cough in the lungs. It may even occur as a consequence to an upper tract infection. Frequently, it occurs in people with weakened immunity, and in geriatric population and children. Biotechnological methods can be approached for testing of pneumonia such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). The global pneumonia testing market was valued at $932 million in 2016, and is estimated to reach $1,738 million by 2023, registering a CAGR of 9.2% from 2017 to 2023.

3D Printed Drugs Market, Estimated to Reach $278 Million in 2020

Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. The potential market for other 3D printed drugs (moderate growth scenario) is estimated to be $278 million in 2020, and would reach $522 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030. 3D printed drugs are developed by 3D printing technology to treat patients and children affected with dysphagia. These drugs are highly porous in nature and disintegrate rapidly, which eliminate the need to directly swallow the intact high-dose medicine.